QT Imaging Holdings, Inc.

QTI Healthcare Medical Devices

QT Imaging Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.9 million, up 287.9% from fiscal 2024. In the quarter to June 2026, revenue grew 103.2%, EPS fell 78.6%, free cash flow fell 236.3% and total debt rose 286.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

2.41 0.03 +1.26%
Market cap
$34.8M
P/E
0.0×
Fwd P/E
−7.3×
Dividend yield
—
F-score
5/9
Altman Z
0.02
Beneish M
17.42
Dividend safety
n/a

Insider Decisions trades per month

Total buys 0.16
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — 1 — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 22.80%

Capital & Financial Ratios $m

Market Cap 34.83
Revenue 26.43
Net Income (20.42)
Free Cash Flow (12.74)
Net Debt 4.32
Current Ratio 3.10 (at or above 1.5: strong)
Debt/Equity 6.81 (above 2: weak)
P/E ratio 0.00
Fwd P/E (7.25) (negative: loss-making)
P/S ratio 1.35
P/B ratio 15.91 (above 6: high)
Past 5Y EPS Growth —
This Y EPS Growth 45.52% (at or above 15%: strong)
Next Y EPS Growth 104.87% (at or above 15%: strong)
Next Y revenue growth 106.29% (at or above 10%: strong)
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 0 1 10 11
Receivables 0 0 6 7
Inventory 4 3 5 10
Other — — — —
5 5 22 29
2023 2024 2025 Q'26
Payables 1 1 4 3
ST’ Debt 4 5 0 —
Other 0 4 — —
7 10 8 9

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow — — 0.00%
Earnings — — 0.00%
Book Value — — 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 7 7 — — —
’25 3 4 4 8 19
’24 1 2 1 1 5
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (4) (5) — — —
’25 (4) (1) (1) (3) (9)
’24 (6) (1) (2) (1) (10)
’23 (1) (1) 0 (1) (3)
’22 0 0 0 (1) (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (4) (5) — — —
’25 (4) (1) (1) (3) (9)
’24 (6) (1) (2) (1) (10)
’23 (1) (1) 0 (1) (3)
’22 0 0 0 (1) (1)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.25) (0.75) — — —
’25 (1.20) (0.42) (0.47) (0.10) (2.01)
’24 (0.14) (0.90) (0.51) (0.45) (2.13)
’23 (0.59) (0.42) (0.43) (0.47) (1.92)
’22 (0.17) (0.29) (0.18) (0.63) (1.27)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — 147.00 147.15 153.00 5.25 3.11

Analyst estimates 2026–2028

Powerpack
High — — — — — 149.40 155.10 177.00 216.00 46.05
People
People Employees — — — — — 3 3 3 21 32
Revenue/emp, $m — — — — — 0.00 0.00 0.01 0.23 0.59
Income, $m
Income, $m Revenue — — — — — — — 0 5 19
Gross margin, % — — — — — — — (234.16) 54.11 45.36
EBT — — — — — (1) (2) (6) (9) (21)
EBT margin, % — — — — — 0.00 0.00 (15,092.57) (184.48) (111.41)
Net income — — — — — (1) (3) (6) (9) (21)
Depreciation — — — — — — 0 0 0 0
Per share, $
Per share, $ Revenue — — — — — 0.00 0.00 0.01 0.73 1.81
Earnings — — — — — (0.41) (0.35) (1.92) (2.13) (2.01)
Cash flow — — — — — (0.50) (0.58) (0.83) (1.51) (0.86)
Capex — — — — — 0.00 0.00 0.00 (0.01) (0.01)
Free cash flow — — — — — (0.50) (0.58) (0.84) (1.52) (0.87)
Book value — — — — — (3.27) (6.00) (1.67) (1.43) 0.62
Shares, m — — — — — 3 2 3 7 10
Valuation, ×
Valuation, × P/E — — — — — — — 0.00 0.00 0.00
P/S — — — — — — — 12,942.56 9.99 3.38
P/B — — — — — — — 0.00 0.00 9.92
EV/Sales — — — — — — — 13,121.68 11.56 3.07
EV/FCF — — — — — — — (199.48) (5.58) (6.35)
Cash, $m
Cash, $m Operating cash flow — — — — — (1) (1) (3) (10) (9)
Capex — — — — — — — 0 0 0
Free cash flow — — — — — (1) (1) (3) (10) (9)
Balance, $m
Balance, $m Working capital — — — — — 1 (4) (3) (5) 14
Total debt — — — — — 0 2 7 9 5
Net debt — — — — — 0 2 7 8 (6)
Shareholders’ equity — — — — — (9) (13) (5) (10) 6
Returns, %
Returns, % ROA — — — — — 0.00 (2.84) (25.07) (221.53) (144.86)
ROIC — — — — — 0.00 0.00 (161.15) 0.00 (486.51)
ROE — — — — — 0.00 35.62 66.32 190.85 1,363.27
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

QT Imaging Holdings, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
SNWV Sanuwave Health Inc. $44.5M 3.0× — (loss-making) −3.13% (below 0%: shrinking) n/m +86.75% (above 0%: growing) 76.23% (2.88%) Compare
XTNT Xtant Medical Holdings, Inc. $42.5M — (loss-making) — (loss-making) −34.96% (below 0%: shrinking) n/m −881.96% (below 0%: shrinking) 57.88% (39.81%) Compare
RPID Rapid Micro Biosystems, Inc. $42.4M — (loss-making) — (loss-making) +10.91% (above 0%: growing) n/m −23.97% (below 0%: shrinking) 15.05% (152.99%) Compare
NNOX Nano-X Imaging Ltd. $38.6M — (loss-making) — (loss-making) +36.71% (above 0%: growing) n/m −21.37% (below 0%: shrinking) (1,050.87%) (1,334.91%) Compare
CVRX CVRx, Inc. $37.0M — (loss-making) — (loss-making) +15.57% (above 0%: growing) n/m −11.18% (below 0%: shrinking) 87.39% (82.92%) Compare
ELUT Elutia Inc. $34.9M 0.6× — (loss-making) −11.65% (below 0%: shrinking) n/m −2.52% (below 0%: shrinking) 59.62% (327.85%) Compare
QTI QT Imaging Holdings, Inc. $34.8M — (loss-making) — (loss-making) +103.20% (above 0%: growing) n/m −236.31% (below 0%: shrinking) 41.16% (25.07%)
NSYS Nortech Systems Incorporated $29.5M 27.9× 17.5× +9.34% (above 0%: growing) −8.33% (below 0%: shrinking) −1,567.16% (below 0%: shrinking) 17.00% 1.86% Compare
ITOC iTonic Holdings Ltd. $29.3M — — — — — — — Compare
Median of peers $37.8M 3.0× — +9.34% — −21.37% 57.88% (82.92%)

All 149 Medical Devices stocks →

QT Imaging Holdings, Inc. (QTI) key facts

  • Strength: QT Imaging Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.9 million, up 287.9% from fiscal 2024.
  • QT Imaging Holdings, Inc. (QTI) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, QTI traded at $2.41, a market capitalization of $34.8 million.
  • Return on equity was 1,363.3% and debt-to-equity 6.81.
  • Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 0.02 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

QT Imaging Holdings, Inc. (QTI) Latest News

No news at this impact. Lower the threshold for more.

stockrow.com/QTI · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com